More than 80% of immunosuppressed patients with idiopathic inflammatory myopathy achieved seroconversion after receiving the recombinant zoster vaccine, according to data published in Arthritis Care & Research.“Although [the recombinant zoster vaccine (RZV)] has shown an overall favorable safety profile in patients with [autoimmune rheumatic diseases (ARDs)], concerns persist regarding vaccination in [idiopathic inflammatory myopathies (IIM)], particularly considering sporadic reports of…
Source: Healio News
